BioCentury | Oct 13, 2003
Company News

BioTransplant, Miltenyi Biotec deal

...The companies amended a June deal under which BTRN is selling its Eligix HDM cell separation...
BioCentury | Jun 9, 2003
Company News

BioTransplant, Miltenyi Biotec deal

...BTRN is selling its Eligix HDM cell separation systems to Miltenyi for $450,000 plus 4%-10% royalties...
BioCentury | Dec 9, 2002
Company News

BioTransplant, Gambro deal

...BTRN and Gambro mututally terminated their European distribution deal for BTRN’s Eligix HDM cell separation systems...
...terminated, BTRN will pay an undisclosed sum to repurchase unused inventory. BTRN plans to repartner Eligix...
BioCentury | Nov 18, 2002
Company News

BioTransplant transplant news

...SSE:GAMB, Stockholm, Sweden) that BTRN believes GAMB is breaching their European distribution deal for BTRN's Eligix...
BioCentury | Nov 15, 2002
Company News

BioTransplant restructures

...partner Gambro (SSE:GAMB) that BTRN believes GAMB is breaching their European distribution deal for BTRN's Eligix...
BioCentury | Oct 14, 2002
Strategy

Spendthrifty

...of 2003. BTRN has not had a late-stage product blow up; instead, sales of its Eligix...
...Data are expected next spring. The company has received European CE mark approval for its Eligix...
...to Europe to work with partner Gambro AB (SSE:GAMB, Stockholm, Sweden) to "galvanize sales of Eligix."...
BioCentury | Aug 5, 2002
Company News

BioTransplant cancer, autoimmune/inflammation, transplant news

...of a restructuring program to focus on BTRN's AlloMune System to treat hematologic malignancies and Eligix...
BioCentury | Jul 29, 2002
Clinical News

Eligix CD8-SC System regulatory update

...BTRN received European CE Mark approval for its Eligix system to separate CD8+ T cells from...
...marrow and peripheral stem cell transplantation for hematological disorders. BioTransplant Inc. (BTRN), Charlestown, Mass. Product: Eligix...
BioCentury | Jul 26, 2002
Company News

Europe approves BTRN cell separation product

...BioTransplant (BTRN) received European CE Mark approval for its Eligix CD8-SC cell separation technology to separate...
BioCentury | Apr 8, 2002
Clinical News

Eligix CD8-HDM System: Physician study

...trial, 2 of 9 patients with leukemia or lymphoma given CD8 depleted PBSC using the Eligix...
...at the European Bone Marrow Transplant meeting in Montreux. BioTransplant Inc. (BTRN), Charlestown, Mass. Product: Eligix...
Items per page:
1 - 10 of 31
BioCentury | Oct 13, 2003
Company News

BioTransplant, Miltenyi Biotec deal

...The companies amended a June deal under which BTRN is selling its Eligix HDM cell separation...
BioCentury | Jun 9, 2003
Company News

BioTransplant, Miltenyi Biotec deal

...BTRN is selling its Eligix HDM cell separation systems to Miltenyi for $450,000 plus 4%-10% royalties...
BioCentury | Dec 9, 2002
Company News

BioTransplant, Gambro deal

...BTRN and Gambro mututally terminated their European distribution deal for BTRN’s Eligix HDM cell separation systems...
...terminated, BTRN will pay an undisclosed sum to repurchase unused inventory. BTRN plans to repartner Eligix...
BioCentury | Nov 18, 2002
Company News

BioTransplant transplant news

...SSE:GAMB, Stockholm, Sweden) that BTRN believes GAMB is breaching their European distribution deal for BTRN's Eligix...
BioCentury | Nov 15, 2002
Company News

BioTransplant restructures

...partner Gambro (SSE:GAMB) that BTRN believes GAMB is breaching their European distribution deal for BTRN's Eligix...
BioCentury | Oct 14, 2002
Strategy

Spendthrifty

...of 2003. BTRN has not had a late-stage product blow up; instead, sales of its Eligix...
...Data are expected next spring. The company has received European CE mark approval for its Eligix...
...to Europe to work with partner Gambro AB (SSE:GAMB, Stockholm, Sweden) to "galvanize sales of Eligix."...
BioCentury | Aug 5, 2002
Company News

BioTransplant cancer, autoimmune/inflammation, transplant news

...of a restructuring program to focus on BTRN's AlloMune System to treat hematologic malignancies and Eligix...
BioCentury | Jul 29, 2002
Clinical News

Eligix CD8-SC System regulatory update

...BTRN received European CE Mark approval for its Eligix system to separate CD8+ T cells from...
...marrow and peripheral stem cell transplantation for hematological disorders. BioTransplant Inc. (BTRN), Charlestown, Mass. Product: Eligix...
BioCentury | Jul 26, 2002
Company News

Europe approves BTRN cell separation product

...BioTransplant (BTRN) received European CE Mark approval for its Eligix CD8-SC cell separation technology to separate...
BioCentury | Apr 8, 2002
Clinical News

Eligix CD8-HDM System: Physician study

...trial, 2 of 9 patients with leukemia or lymphoma given CD8 depleted PBSC using the Eligix...
...at the European Bone Marrow Transplant meeting in Montreux. BioTransplant Inc. (BTRN), Charlestown, Mass. Product: Eligix...
Items per page:
1 - 10 of 31